← Home
🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Lonza Group 
Pharma / Pharmaceutical and Biotechnology Manufacturing
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebOverview
The Lonza Group is a leading global supplier to the pharmaceutical, biotech, and specialty ingredients markets. The company focuses on research, development, and manufacturing of innovative products and services in the areas of life sciences and specialty chemicals. Headquartered in Basel, Switzerland, Lonza Group was founded in 1897 and has operations in around 120 locations worldwide, employing approximately 15,500 people. The company has a strong presence in Europe, North America, and Asia, and provides a wide range of products and services to various industries, including healthcare, nutrition, coatings, and composites.
Some key facts about Lonza Group include:
- Lonza Group is listed on the SIX Swiss Exchange and is a component of the Swiss Market Index.
- The company generated sales of CHF 5.9 billion in 2019.
- Lonza Group’s three main business segments are Pharma Biotech & Nutrition, Specialty Ingredients, and Microbial Control.
- The company’s products and services range from active pharmaceutical ingredients (APIs) and drug product intermediates to delivery systems and bioavailability enhancers.
- Lonza Group has a strong focus on sustainability and has set ambitious goals to reduce its environmental impact and promote responsible business practices.
- The company has a diverse workforce and is committed to diversity and inclusion in the workplace.
- Lonza Group has a history of strategic partnerships and collaborations with other companies and organizations in the life sciences and specialty chemicals industries.
Some key facts about Lonza Group include:
- Lonza Group is listed on the SIX Swiss Exchange and is a component of the Swiss Market Index.
- The company generated sales of CHF 5.9 billion in 2019.
- Lonza Group’s three main business segments are Pharma Biotech & Nutrition, Specialty Ingredients, and Microbial Control.
- The company’s products and services range from active pharmaceutical ingredients (APIs) and drug product intermediates to delivery systems and bioavailability enhancers.
- Lonza Group has a strong focus on sustainability and has set ambitious goals to reduce its environmental impact and promote responsible business practices.
- The company has a diverse workforce and is committed to diversity and inclusion in the workplace.
- Lonza Group has a history of strategic partnerships and collaborations with other companies and organizations in the life sciences and specialty chemicals industries.
What is special about the company?
1. Global Presence: The Lonza Group is a global company with operations in over 120 locations across six continents. This allows the company to serve a diverse customer base and tap into various markets worldwide.
2. Diverse Product Portfolio: The company’s product portfolio encompasses a wide range of products and services in the fields of biopharmaceuticals, specialty chemicals, and microbial control. This diversity enables the company to cater to various industries, including pharmaceuticals, biotechnology, nutrition, and medical devices.
3. Innovative Technologies: Lonza Group is focused on developing innovative technologies to address the growing demand for advanced healthcare and sustainable solutions. Its research and development efforts have resulted in several breakthrough technologies, including cell therapy, next-generation vaccines, and gene therapy.
4. Strong Manufacturing Capabilities: The company has state-of-the-art manufacturing facilities that adhere to the highest quality standards, enabling it to produce high-quality products consistently. This has helped Lonza to gain a reputation for reliability and consistency in its products and services.
5. Commitment to Sustainability: Lonza is committed to sustainable practices and has implemented several initiatives to minimize its environmental impact. The company focuses on reducing waste, energy consumption, and water consumption in its operations and products.
6. Emphasis on Quality and Safety: The Lonza Group has a strong focus on quality and safety, which is reflected in its robust quality management systems. The company’s products and services are manufactured in compliance with strict regulations and standards to ensure the safety and efficacy of its offerings.
7. Strong Customer Relationships: The company values its customers and strives to develop strong and long-lasting relationships with them. It works closely with its clients, understanding their specific needs and providing tailored solutions to meet their requirements effectively.
8. Commitment to Employee Development: Lonza is committed to the growth and development of its employees. The company provides various training and development programs to its employees to enhance their skills and knowledge, ensuring a highly skilled and motivated workforce.
9. Social Responsibility: The Lonza Group is dedicated to being a responsible corporate citizen and actively participates in various social responsibility initiatives. The company supports various programs and activities that promote education, health, and community development.
10. Strong Financial Performance: Lonza has consistently delivered strong financial performance, with steady revenue growth and profitability. This financial stability has allowed the company to reinvest in its business and pursue strategic growth opportunities, ensuring its long-term success.
2. Diverse Product Portfolio: The company’s product portfolio encompasses a wide range of products and services in the fields of biopharmaceuticals, specialty chemicals, and microbial control. This diversity enables the company to cater to various industries, including pharmaceuticals, biotechnology, nutrition, and medical devices.
3. Innovative Technologies: Lonza Group is focused on developing innovative technologies to address the growing demand for advanced healthcare and sustainable solutions. Its research and development efforts have resulted in several breakthrough technologies, including cell therapy, next-generation vaccines, and gene therapy.
4. Strong Manufacturing Capabilities: The company has state-of-the-art manufacturing facilities that adhere to the highest quality standards, enabling it to produce high-quality products consistently. This has helped Lonza to gain a reputation for reliability and consistency in its products and services.
5. Commitment to Sustainability: Lonza is committed to sustainable practices and has implemented several initiatives to minimize its environmental impact. The company focuses on reducing waste, energy consumption, and water consumption in its operations and products.
6. Emphasis on Quality and Safety: The Lonza Group has a strong focus on quality and safety, which is reflected in its robust quality management systems. The company’s products and services are manufactured in compliance with strict regulations and standards to ensure the safety and efficacy of its offerings.
7. Strong Customer Relationships: The company values its customers and strives to develop strong and long-lasting relationships with them. It works closely with its clients, understanding their specific needs and providing tailored solutions to meet their requirements effectively.
8. Commitment to Employee Development: Lonza is committed to the growth and development of its employees. The company provides various training and development programs to its employees to enhance their skills and knowledge, ensuring a highly skilled and motivated workforce.
9. Social Responsibility: The Lonza Group is dedicated to being a responsible corporate citizen and actively participates in various social responsibility initiatives. The company supports various programs and activities that promote education, health, and community development.
10. Strong Financial Performance: Lonza has consistently delivered strong financial performance, with steady revenue growth and profitability. This financial stability has allowed the company to reinvest in its business and pursue strategic growth opportunities, ensuring its long-term success.
What the company's business model?
The Lonza Group is a global life sciences company that specializes in providing products and services to benefit the healthcare, pharmaceutical, and biotechnology industries. The company’s business model is based on three main pillars: Custom Development and Manufacturing, Specialty Ingredients, and Consumer Health.
Custom Development and Manufacturing: This segment focuses on providing contract development and manufacturing services to pharmaceutical and biotechnology companies. This includes developing and manufacturing active pharmaceutical ingredients (APIs), drug products, and biologics.
Specialty Ingredients: This segment offers a wide range of specialty chemicals, cell culture and diagnostic solutions, and bioscience products for various industries such as healthcare, nutrition, and agrochemicals.
Consumer Health: This segment provides a variety of consumer health products and services, including nutritional supplements, over-the-counter pharmaceuticals, and cosmetic ingredients.
Overall, Lonza’s business model is centered around providing customized solutions and products to its clients in the healthcare, pharmaceutical, and biotechnology sectors. The company’s extensive expertise in cell and molecular technologies allows it to deliver high-quality and innovative products and services to meet the needs of its customers.
Custom Development and Manufacturing: This segment focuses on providing contract development and manufacturing services to pharmaceutical and biotechnology companies. This includes developing and manufacturing active pharmaceutical ingredients (APIs), drug products, and biologics.
Specialty Ingredients: This segment offers a wide range of specialty chemicals, cell culture and diagnostic solutions, and bioscience products for various industries such as healthcare, nutrition, and agrochemicals.
Consumer Health: This segment provides a variety of consumer health products and services, including nutritional supplements, over-the-counter pharmaceuticals, and cosmetic ingredients.
Overall, Lonza’s business model is centered around providing customized solutions and products to its clients in the healthcare, pharmaceutical, and biotechnology sectors. The company’s extensive expertise in cell and molecular technologies allows it to deliver high-quality and innovative products and services to meet the needs of its customers.
Interesting facts about the company
1. The Lonza Group was founded in 1897 in Gampel, Switzerland by Emil Albrecht and his three sons.
2. Originally, the company was called Albrecht & Co., and it specialized in manufacturing and selling dyestuffs.
3. In the 1920s, the company shifted its focus to manufacturing and selling specialty chemicals.
4. In the 1960s, the company began its expansion into the pharmaceutical industry by acquiring a Swiss pharmaceutical company called Dr. Siegfried AG.
5. Today, the Lonza Group is a leading supplier to the biotechnology and pharmaceutical industries, with a wide range of products and services.
6. The company has over 15,000 employees and operates in more than 35 countries around the world.
7. Lonza’s headquarters are located in Basel, Switzerland and it has a global research and development center in Visp, Switzerland.
8. The company’s stock is listed on the SIX Swiss Exchange and it has been a component of the Swiss Market Index (SMI) since 2004.
9. In 2020, Lonza was listed as the top contract manufacturing organization (CMO) by the Global Top 50 Pharma and Biopharma CMOs report.
10. The company’s name, Lonza, comes from the Latin word for pool or lake, reflecting its location near the Rhône River in Switzerland.
See Company Due Diligence:
2. Originally, the company was called Albrecht & Co., and it specialized in manufacturing and selling dyestuffs.
3. In the 1920s, the company shifted its focus to manufacturing and selling specialty chemicals.
4. In the 1960s, the company began its expansion into the pharmaceutical industry by acquiring a Swiss pharmaceutical company called Dr. Siegfried AG.
5. Today, the Lonza Group is a leading supplier to the biotechnology and pharmaceutical industries, with a wide range of products and services.
6. The company has over 15,000 employees and operates in more than 35 countries around the world.
7. Lonza’s headquarters are located in Basel, Switzerland and it has a global research and development center in Visp, Switzerland.
8. The company’s stock is listed on the SIX Swiss Exchange and it has been a component of the Swiss Market Index (SMI) since 2004.
9. In 2020, Lonza was listed as the top contract manufacturing organization (CMO) by the Global Top 50 Pharma and Biopharma CMOs report.
10. The company’s name, Lonza, comes from the Latin word for pool or lake, reflecting its location near the Rhône River in Switzerland.
See Company Due Diligence:
Wait! There's more — sign up for free or log in